Sample Placebo Response Data

----------------------------------------------------------------------------------------------------------

Schizophrenia Study

------------------------------------------------------------------------------

Enrollment Metrics

Our individual sites have varied strengths, specialties and successes. Sample metrics from the group’s recent studies include:

• Schizophrenia inpatient: 49 screened, 38 randomized over 12 months
• Schizophrenia outpatient: 19 screened, 18 randomized over 8 months
• Cognition in schizophrenia: 35 screened, 28 randomized over 15 months
• Bipolar mania inpatient: 29 screened, 20 randomized over 8 months
• Bipolar mania outpatient: 18 screened, 16 randomized over 6 months
• Major depression: 37 screened, 30 randomized over 5 months
• Treatment-resistant depression: 47 screened, 37 randomized over 16 months
• Generalized Anxiety Disorder: 24 screened, 15 randomized over 10 months
• Adult ADHD: 19 screened, 11 randomized over 3 months
• Bipolar depression: 24 screened, 15 randomized over 12 months
• Insomnia, outpatient: 60 screened, 50 randomized over 7 months
• Insomnia, PSG: 22 screened, 20 randomized over 6 months
• Restless legs syndrome: 18 screened, 9 randomized over 11 months
• Phase I schizophrenia QTc study completed 8 of 8 subjects enrolled in one month
• Sponsor commendations for low placebo response on multiple depression protocols